Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Harvard Business School
Medtronic
Mallinckrodt

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Litigation Details for ALPEX PHARMA, S.A. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ALPEX PHARMA, S.A. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2013)

Docket   Start Trial Date Filed 2013-07-01
Court District Court, D. New Jersey Date Terminated 2013-10-16
Cause 35:145 Patent Infringement Assigned To Noel Lawrence Hillman
Jury Demand None Referred To Joel Schneider
Parties ALPEX PHARMA, S.A.; CADILA HEALTHCARE LIMITED; CITIUS PHARMACEUTICALS, LLC.; PRENZAMAX, LLC.; ZYDUS PHARMACEUTICALS USA, INC.
Patents 6,149,938
Attorneys GEORGE C. JONES; THOMAS R. CURTIN
Firms George C. Jones; Thomas R Curtin
Link to Docket External link to docket
Small Molecule Drugs cited in ALPEX PHARMA, S.A. v. ZYDUS PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for ALPEX PHARMA, S.A. v. ZYDUS PHARMACEUTICALS USA, INC. (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-07-01 1 is an action for patent infringement of U.S. Patent No. 6,149,938 (“the ‘938 patent”), arising under…copy of the ‘938 patent is attached hereto as Exhibit A. The claims of the ‘938 patent are valid and enforceable…infringement of the ‘938 patent. Prenzamax is an exclusive sub-licensee of the ‘938 patent with respect to SUPRENZA…covered by one or more claims of the ‘938 patent. The ‘938 patent has been listed in connection with SUPRENZA…respect to the ‘938 patent. Zydus has certified that no valid claim of the ‘938 patent will be infringed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Harvard Business School
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.